NIH-funded research Sbir 2 grant

New method to purify DNA/RNA from archived tissue to enable better sequencing

Official title: Developing a New Nucleic Acid Extraction Technology to Enable High Quality DNA Sequencing for Formalin Fixed Paraffin Embedded Tissue Samples

Funded at Vellum Biotechnology, INC. · NIH-11337585 · Data updated 2026-11-12

A new method using epitachophoresis to extract high-quality nucleic acids from formalin-fixed paraffin-embedded tissue, helping researchers get better DNA and RNA data from precious patient samples.

Quick facts

Grant typeSbir 2 grant
Study typeNIH-funded research
Funding institutionVellum Biotechnology, INC.
NIH-funded
Lab location1 site (Palo Alto, United States)
Project startJune 1, 2025
Project endMay 31, 2027
Funding year2026
Award (this year)$1,014,715
NIH project number5R44HG014445-02
Project IDNIH-11337585 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are researchers or clinicians who rely on high-quality DNA/RNA from FFPE tissue for sequencing and biomarker studies.

Less likely to help

Patients whose tissue samples are not FFPE or whose sequencing needs are unrelated to FFPE-derived nucleic acids may not benefit.

What this research studies

This project aims to improve the way we purify DNA and RNA from long-stored FFPE tissue samples so next-generation sequencing can produce higher-quality results. The team will develop epitachophoresis-based purification in a circular-well system to reduce contamination and variability. If successful, this could unlock more reliable sequencing data from archived patient tissues that are already available in biobanks. The work focuses on overcoming technical barriers, with the goal of enabling more accurate diagnostics and research findings from FFPE samples.

Why it matters

Potential benefit: If successful, patients could benefit from faster, more accurate sequencing of archived tumor or tissue samples, potentially guiding future diagnostics and therapies.

How similar studies have gone: Previous methods often struggle with yield and quality from FFPE; this work aims to overcome these issues with a novel purification approach, offering potential for improved results.

Where this research is happening

  • Vellum Biotechnology, INC.
    Palo Alto, United States
    Active

Researchers

  • Principal investigator: Astier, Yann — Vellum Biotechnology, INC.
  • Study coordinator: Astier, Yann

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.